246 related articles for article (PubMed ID: 29688280)
1. The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment.
Nota NM; Wiepjes CM; de Blok CJM; Gooren LJG; Peerdeman SM; Kreukels BPC; den Heijer M
Brain; 2018 Jul; 141(7):2047-2054. PubMed ID: 29688280
[TBL] [Abstract][Full Text] [Related]
2. Gender-Affirming Hormone Treatment Induces Facial Feminization in Transwomen and Masculinization in Transmen: Quantification by 3D Scanning and Patient-Reported Outcome Measures.
Tebbens M; Nota NM; Liberton NPTJ; Meijer BA; Kreukels BPC; Forouzanfar T; Verdaasdonk RM; den Heijer M
J Sex Med; 2019 May; 16(5):746-754. PubMed ID: 30926514
[TBL] [Abstract][Full Text] [Related]
3. Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review.
Mancini I; Rotilio A; Coati I; Seracchioli R; Martelli V; Meriggiola MC
Gynecol Endocrinol; 2018 Jun; 34(6):456-459. PubMed ID: 29105524
[TBL] [Abstract][Full Text] [Related]
4. Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents.
Vlot MC; Klink DT; den Heijer M; Blankenstein MA; Rotteveel J; Heijboer AC
Bone; 2017 Feb; 95():11-19. PubMed ID: 27845262
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol.
Arnold JD; Sarkodie EP; Coleman ME; Goldstein DA
J Sex Med; 2016 Nov; 13(11):1773-1777. PubMed ID: 27671969
[TBL] [Abstract][Full Text] [Related]
6. The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets.
Wiepjes CM; Nota NM; de Blok CJM; Klaver M; de Vries ALC; Wensing-Kruger SA; de Jongh RT; Bouman MB; Steensma TD; Cohen-Kettenis P; Gooren LJG; Kreukels BPC; den Heijer M
J Sex Med; 2018 Apr; 15(4):582-590. PubMed ID: 29463477
[TBL] [Abstract][Full Text] [Related]
7. Cardiometabolic Effects of Testosterone in Transmen and Estrogen Plus Cyproterone Acetate in Transwomen.
van Velzen DM; Paldino A; Klaver M; Nota NM; Defreyne J; Hovingh GK; Thijs A; Simsek S; T'Sjoen G; den Heijer M
J Clin Endocrinol Metab; 2019 Jun; 104(6):1937-1947. PubMed ID: 30602016
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer development in transsexual subjects receiving cross-sex hormone treatment.
Gooren LJ; van Trotsenburg MA; Giltay EJ; van Diest PJ
J Sex Med; 2013 Dec; 10(12):3129-34. PubMed ID: 24010586
[TBL] [Abstract][Full Text] [Related]
9. Early Hormonal Treatment Affects Body Composition and Body Shape in Young Transgender Adolescents.
Klaver M; de Mutsert R; Wiepjes CM; Twisk JWR; den Heijer M; Rotteveel J; Klink DT
J Sex Med; 2018 Feb; 15(2):251-260. PubMed ID: 29425666
[TBL] [Abstract][Full Text] [Related]
10. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.
Asscheman H; Giltay EJ; Megens JA; de Ronde WP; van Trotsenburg MA; Gooren LJ
Eur J Endocrinol; 2011 Apr; 164(4):635-42. PubMed ID: 21266549
[TBL] [Abstract][Full Text] [Related]
11. Effect of gender-affirming hormone use on coagulation profiles in transmen and transwomen.
Scheres LJJ; Selier NLD; Nota NM; van Diemen JJK; Cannegieter SC; den Heijer M
J Thromb Haemost; 2021 Apr; 19(4):1029-1037. PubMed ID: 33527671
[TBL] [Abstract][Full Text] [Related]
12. Consecutive Cyproterone Acetate and Estradiol Treatment in Late-Pubertal Transgender Female Adolescents.
Tack LJW; Heyse R; Craen M; Dhondt K; Bossche HV; Laridaen J; Cools M
J Sex Med; 2017 May; 14(5):747-757. PubMed ID: 28499525
[TBL] [Abstract][Full Text] [Related]
13. Gender-Affirming Hormone Treatment Decreases Bone Turnover in Transwomen and Older Transmen.
Vlot MC; Wiepjes CM; de Jongh RT; T'Sjoen G; Heijboer AC; den Heijer M
J Bone Miner Res; 2019 Oct; 34(10):1862-1872. PubMed ID: 31099910
[TBL] [Abstract][Full Text] [Related]
14. Gender-Affirming Hormone Therapy Modifies the CpG Methylation Pattern of the ESR1 Gene Promoter After Six Months of Treatment in Transmen.
Fernández R; Ramírez K; Gómez-Gil E; Cortés-Cortés J; Mora M; Aranda G; Zayas ED; Esteva I; Almaraz MC; Guillamon A; Pásaro E
J Sex Med; 2020 Sep; 17(9):1795-1806. PubMed ID: 32636163
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Eating Disorder Psychopathology within the Treatment Seeking Transgender Population: The Role of Cross-Sex Hormone Treatment.
Jones BA; Haycraft E; Bouman WP; Brewin N; Claes L; Arcelus J
Eur Eat Disord Rev; 2018 Mar; 26(2):120-128. PubMed ID: 29318711
[TBL] [Abstract][Full Text] [Related]
16. Variation in sensitivity and rate of change in body composition: steps toward individualizing transgender care.
van Velzen DM; Nota NM; Simsek S; Conemans EB; T'Sjoen G; den Heijer M
Eur J Endocrinol; 2020 Nov; 183(5):529-536. PubMed ID: 33071222
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands.
de Blok CJM; Wiepjes CM; Nota NM; van Engelen K; Adank MA; Dreijerink KMA; Barbé E; Konings IRHM; den Heijer M
BMJ; 2019 May; 365():l1652. PubMed ID: 31088823
[TBL] [Abstract][Full Text] [Related]
18. Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study.
Klaver M; de Blok CJM; Wiepjes CM; Nota NM; Dekker MJHJ; de Mutsert R; Schreiner T; Fisher AD; T'Sjoen G; den Heijer M
Eur J Endocrinol; 2018 Feb; 178(2):163-171. PubMed ID: 29183889
[TBL] [Abstract][Full Text] [Related]
19. Hormonal Treatment Effect on Sexual Distress in Transgender Persons: 2-Year Follow-Up Data.
Ristori J; Cocchetti C; Castellini G; Pierdominici M; Cipriani A; Testi D; Gavazzi G; Mazzoli F; Mosconi M; Meriggiola MC; Cassioli E; Vignozzi L; Ricca V; Maggi M; Fisher AD
J Sex Med; 2020 Jan; 17(1):142-151. PubMed ID: 31735612
[TBL] [Abstract][Full Text] [Related]
20. Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study.
de Blok CJM; Klaver M; Wiepjes CM; Nota NM; Heijboer AC; Fisher AD; Schreiner T; T'Sjoen G; den Heijer M
J Clin Endocrinol Metab; 2018 Feb; 103(2):532-538. PubMed ID: 29165635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
